We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nobel Prize Winner to Address Annual Pathology Meeting

By Labmedica staff writers
Posted on 20 Sep 2006
The pathologist's role in patient safety, advances in molecular pathology for early disease diagnoses, and the newest clinical laboratory tests are among the many issues to be explored at the 2006 Annual Meeting of The American Society for Clinical Pathology (ASCP), October 18-22, in Las Vegas (Nevada, USA). More...
Nobel Prize winner Louis J. Ignarro, Ph.D., of the University of California, Los Angeles (UCLA, USA), will give the opening keynote address.

Dr. Ignarro will present a historical perspective of his research, including his experiences in Stockholm as he received the Nobel Prize. His experimentation led to the discovery that nitric oxide is the neurotransmitter responsible for penile erection. Dr. Ignarro's research made it possible for medical professionals to understand what protects the cardiovascular system against pathologic conditions, such as hypertension and atherosclerosis. His studies have also resulted in a new understanding of cardiovascular system pathology, and contributed to the development of a variety of pharmaceuticals, including Viagra (sildenafil, Pfizer).

On October 20, Ralph L. Nachman, M.D., professor and chair, department of medicine Weill Cornell Medical College (New York, NY, USA), will give the scientific keynote address entitled "To Clot or Not to Clot: a Clinical Challenge.” He will talk about how chronologic advances, new discoveries in molecular genetics, and serendipity have furthered the understanding of coagulation and fibrinolytic systems. Dr. Nachman will address hypercoagulable states from their molecular biology to their clinical consequences.

Ralph H. Hruban, M.D., professor, pathology and oncology, The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins University (Baltimore, MD, USA), will present the Arthur Purdy Stout Keynote address on October 21. His lecture is entitled "Tumors of the Pancreas: From Genes to Diagnostic Pathology.” He will present an overview of the pathobiology of pancreatic neoplasia with emphasis on the application of the latest technologies to diagnose pancreatic pathology.

At the meeting, pathologists will learn about other new topics and concepts, take interactive and dynamic courses, and share ideas and strategies to deal with the toughest challenges in pathology. There will be numerous exhibits displaying state-of-the-art technology, products, and services for pathologists and laboratory professionals.



Related Links:
American Society for Clinical Pathology

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.